simendan has been researched along with Cardiac Remodeling, Ventricular in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Yu, S; Zhang, J | 1 |
| Duvall, E; Haavisto, M; Kentala, R; Knuuti, J; Levijoki, J; Nyman, L; Pietilä, M; Roivainen, A; Saraste, A; Saukko, P; Saunavaara, V; Savunen, T; Stark, C; Strandberg, M; Tarkia, M; Teräs, M; Tolvanen, T; Vähäsilta, T | 1 |
| Finckenberg, P; Forsten, H; Kaheinen, P; Kytö, V; Leskinen, H; Levijoki, J; Louhelainen, M; Merasto, S; Mervaala, E; Tikkanen, I; Vahtola, E | 1 |
| Kaheinen, P; Lakkisto, J; Lakkisto, P; Levijoki, J; Louhelainen, M; Merasto, S; Mervaala, E; Storvik, M; Tikkanen, I; Vahtola, E | 1 |
| Biala, A; Finckenberg, P; Korpi, A; Levijoki, J; Loytainen, M; Martonen, E; Mervaala, E | 1 |
| Cam, N; Kasikcioglu, HA | 1 |
| Colucci, WS; Finckenberg, P; Haikala, H; Kaheinen, P; Kytö, V; Leskinen, H; Levijoki, J; Louhelainen, M; Merasto, S; Mervaala, EM; Pollesello, P; Vahtola, E | 1 |
1 review(s) available for simendan and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
A review of levosimendan in the treatment of heart failure.
Topics: Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Cardiotonic Agents; Coronary Circulation; Drug Therapy, Combination; Heart Failure; Humans; Hydrazones; Matrix Metalloproteinases; Myocardial Contraction; Myocardial Stunning; Neurosecretory Systems; Practice Guidelines as Topic; Pyridazines; Simendan; Treatment Outcome; Ventricular Remodeling | 2006 |
1 trial(s) available for simendan and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Effects of Levosimendan Preconditioning on Left Ventricular Remodeling after Myocardial Reperfusion in Acute Myocardial Infarction Patients Receiving Percutaneous Coronary Intervention.
Topics: Humans; Myocardial Infarction; Myocardial Reperfusion; Percutaneous Coronary Intervention; Simendan; Stroke Volume; Ventricular Function, Left; Ventricular Remodeling | 2022 |
5 other study(ies) available for simendan and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Effect of levosimendan therapy on myocardial infarct size and left ventricular function after acute coronary occlusion.
Topics: Acute Disease; Animals; Cardiotonic Agents; Coronary Occlusion; Diastole; Disease Models, Animal; Follow-Up Studies; Hydrazones; Male; Myocardial Contraction; Myocardial Infarction; Myocardium; Pyridazines; Simendan; Stroke Volume; Swine; Systole; Ventricular Function, Left; Ventricular Remodeling | 2016 |
Oral levosimendan prevents postinfarct heart failure and cardiac remodeling in diabetic Goto-Kakizaki rats.
Topics: Administration, Oral; Animals; Apoptosis; Blood Pressure; Cardiomegaly; Cardiotonic Agents; Cyclin-Dependent Kinase Inhibitor p16; Diabetes Complications; Diabetes Mellitus, Type 2; Disease Models, Animal; Heart Failure; Homeodomain Proteins; Hydrazones; Male; Myocardial Infarction; Pyridazines; Rats; Rats, Mutant Strains; Rats, Wistar; RNA, Messenger; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Simendan; STAT1 Transcription Factor; Ventricular Remodeling | 2009 |
Effects of levosimendan on cardiac gene expression profile and post-infarct cardiac remodelling in diabetic Goto-Kakizaki rats.
Topics: Animals; Diabetes Mellitus, Experimental; Down-Regulation; Gene Expression Profiling; Heart; Heart Failure; Hydrazones; Immunohistochemistry; Microarray Analysis; Myocardial Infarction; Myocardium; Pyridazines; Rats; Rats, Wistar; Renin-Angiotensin System; Simendan; Transcriptome; Up-Regulation; Ventricular Remodeling | 2011 |
Cardiovascular effects of the combination of levosimendan and valsartan in hypertensive Dahl/Rapp rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Blood Pressure; Cardiomegaly; Cardiovascular Diseases; Diet, Sodium-Restricted; Echocardiography; Heart; Heart Failure; Heart Rate; Hydrazones; Hypertension; Kidney; Male; Myocytes, Cardiac; Pyridazines; Rats; Rats, Inbred Dahl; RNA, Messenger; Simendan; Sodium Chloride, Dietary; Sodium, Dietary; Tetrazoles; Valine; Valsartan; Vasodilator Agents; Ventricular Remodeling | 2011 |
Effects of levosimendan on cardiac remodeling and cardiomyocyte apoptosis in hypertensive Dahl/Rapp rats.
Topics: Animals; Apoptosis; Atrial Natriuretic Factor; Hydrazones; Hypertension; Male; Myocardium; Myocytes, Cardiac; Natriuretic Peptide, Brain; Norepinephrine; Osteopontin; Pyridazines; Rats; Rats, Inbred Dahl; RNA, Messenger; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Simendan; Sodium-Calcium Exchanger; Vasodilator Agents; Ventricular Remodeling | 2007 |